U.S. Markets closed

OncoMed Pharmaceuticals, Inc. (OMED)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
4.47+0.06 (+1.36%)
At close: 4:00PM EDT
People also watch
EPZMXLRNMGNXKPTIONTX
Full screen
Previous Close4.41
Open4.37
Bid1.13 x 100
Ask5.50 x 10000
Day's Range4.34 - 4.52
52 Week Range2.91 - 12.24
Volume140,920
Avg. Volume229,973
Market Cap168.21M
Beta2.78
PE Ratio (TTM)-1.89
EPS (TTM)-2.36
Earnings DateOct 30, 2017 - Nov 3, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.13
Trade prices are not sourced from all markets
  • GlobeNewswire4 days ago

    OncoMed Chairman and CEO, Paul Hastings, to Take Medical Leave of Absence

    REDWOOD CITY, Calif., Sept. 19, 2017-- OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced that ...

  • GlobeNewswire10 days ago

    OncoMed Doses First Patient with GITRL-Fc in Phase 1a Clinical Trial

    REDWOOD CITY, Calif., Sept. 13, 2017-- OncoMed Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, announced today that ...

  • Capital Cube23 days ago

    ETFs with exposure to OncoMed Pharmaceuticals, Inc. : August 31, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to OncoMed Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to OMED-US. Comparing the performance and risk of OncoMed Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)